HealthCanada Embraces an Orphan Drug Framework

Cara Hesse | December 11, 2012

This past month, 2.8 million Canadians with rare diseases had cause to celebrate with two announcements from the Canadian Government. Reversing a 16-year old policy, HealthCanada will now establish a rare disease framework that could potentially lea...

Read more...

Global Reach: Thyroid Cancer Awareness Month

Alan Gilstrap | November 27, 2012

Genzyme was pleased to recognize September as Thyroid Cancer Awareness Month in a number of ways, both internally and externally. Members of the Endocrinology business unit across Genzyme and Sanofi channeled key opinion leaders around the globe las...

Read more...

Pages